AnalystsMichael FreemanMichael Freeman's Stock Forecasts
AnalystsMichael Freeman
Sectors:
Analyst Ranking
Top 43%
#2222 out of 5209 analysts
Average Return
+15.61%
Win Rate
80%4 out of 5
Risk vs Reward
Poor
Good
Michael Freeman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Wave Life Sciences LtdWVE | +90.68% | $7.19 | $13.71 | 2025-06-11 - 2026-03-04 | Buy |
Disc Medicine IncIRON | +20.13% | $50.86 | $61.10 | 2025-06-11 - 2026-03-04 | Strong Buy |
Tectonic Therapeutic IncTECX | +16.64% | $23.50 | $27.41 | 2025-06-11 - 2026-03-04 | Buy |
Dyne Therapeutics IncDYN | +4.53% | $14.57 | $15.23 | 2025-06-11 - 2026-03-04 | Buy |
Michael Freeman Analyst Color
Get additional color on Michael Freeman's coverage of popular stocks
Michael Freeman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Wave Life Sciences LtdWVE | 1 | Buy | $14.00 | +2.12% | Assumes | 9 months ago |
Tectonic Therapeutic IncTECX | 1 | Buy | $76.00 | +177.27% | Reinstates | 9 months ago |
Dyne Therapeutics IncDYN | 1 | Buy | $37.00 | +142.94% | Assumes | 9 months ago |
Disc Medicine IncIRON | 1 | Strong Buy | $89.00 | +45.66% | Reinstates | 9 months ago |
Avidity Biosciences IncRNAM | 1 | Strong Buy | $65.00 | +340.68% | Initiates Coverage On | 9 months ago |
Bausch Health Companies IncBHC | 1 | Hold | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.